Imperial Valley News Center
- Written by State Department
Washington, DC - Today, the United States decided to revoke economic sanctions with respect to Sudan and the Government of Sudan under Executive Orders 13067 and 13412, in recognition of the Government of Sudan’s sustained positive actions to maintain a cessation of hostilities in conflict areas in Sudan, improve humanitarian access throughout Sudan, and maintain cooperation with the United States on addressing regional conflicts and the threat of terrorism. The revocation will be effective October 12, 2017. This action came about through a focused, 16-month diplomatic effort to make progress with Sudan in these key areas.
- Written by Danny Ray Nunez Jr.
San Juan, Puerto Rico - The Military Sealift Command hospital ship USNS Comfort (T-AH 20) got underway October 5, to provide aid from the sea in Puerto Rico after completing a planning phase in San Juan with local and federal stakeholders to synchronize efforts to provide humanitarian assistance.
- Written by Timothy Zimmerman
Washington, DC - Cybersecurity, at this point in the technological age, has become a household word. Every week, almost like clockwork, it seems there is a story on the news about a newly discovered hack or data breach often made possible by poor cybersecurity practices. Many of these incidents are focused around stolen data, which resides in our IT, or information technology, infrastructure. However, the breaches that interest me are those that affect the systems and devices that monitor and manipulate much of the world around us and have real-world health and safety consequences if they are compromised. These extremely important systems and devices are known as operational technologies, or OT.
- Written by AT&T
Imperial, California - On September 7, 2017, Equifax announced that it suffered a data breach. There was no breach of AT&T systems or the data we maintain, but we have been working with Equifax to learn more about this event and understand there is a possibility that your personal information might have been exposed.
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration today announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry across the country.
- Written by IVN
Washington, DC - The U.S. Food and Drug Administration today announced it has awarded six new research grants for natural history studies in rare diseases. The aim of the research is to inform medical product development by better understanding how specific rare diseases progress over time. One potential application of these studies is the opportunity to eventually use natural history models to augment the need for placebo arms in studies of drugs that target very rare disease, where trial recruitment can be challenging.
Page 479 of 2514